An Economic Evaluation of Thermostable Vaccines in Cambodia, Ghana, and Bangladesh
This article, published in Vaccine, evaluates the incremental health and programmatic cost impacts of theoretical new vaccine products as compared to the standard vaccine products in multi-dose vials in Cambodia, Ghana, and Bangladesh. The authors use a cost-effectiveness model to estimate the impacts of introducing four thermostable vaccines with single-dose presentations: measles, yellow fever, bacille Calmette-Guerin, and diphtheria–tetanus–pertussis–hepatitis B. The effectiveness of all of the vaccines increases with the thermostable formats. The incremental costs associated with the introduction of thermostable vaccines increases for three out of four vaccines. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Levin A, Levin C, Kristensen D, Matthias D
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Levin A, Levin C, Kristensen D, Matthias D. An Economic Evaluation of Thermostable Vaccines in Cambodia, Ghana, and Bangladesh. Vaccine. 25(39-40):6945-6957.